Division of Medicinal and Natural Products Chemistry, University of Iowa, Iowa City, IA 52242, USA.
Antimicrob Agents Chemother. 2010 Dec;54(12):5214-21. doi: 10.1128/AAC.01054-10. Epub 2010 Sep 20.
Quinolones rapidly kill bacteria by two mechanisms, one that requires protein synthesis and one that does not. The latter, which is measured as lethal action in the presence of the protein synthesis inhibitor chloramphenicol, is enhanced by N-1 cyclopropyl and C-8 methoxy substituents, as seen with the highly lethal compound PD161144. In some compounds, such as levofloxacin, the N-1 and C-8 substituents are fused. To assess the effect of ring fusion on killing, structural derivatives of levofloxacin and PD161144 differing at C-7 were synthesized and examined with Escherichia coli. A fused-ring derivative of PD161144 exhibited a striking absence of lethal activity in the presence of chloramphenicol. In general, ring fusion had little effect on lethal activity when protein synthesis was allowed, but fusion reduced lethal activity in the absence of protein synthesis to extents that depended on the C-7 ring structure. Additional fused-ring fluoroquinolones, pazufloxacin, marbofloxacin, and rufloxacin, also exhibited reduced activity in the presence of chloramphenicol. Energy minimization modeling revealed that steric interactions of the trans-oriented N-1 cyclopropyl and C-8 methoxy moieties skew the quinolone core, rigidly orient these groups perpendicular to core rings, and restrict the rotational freedom of C-7 rings. These features were not observed with fused-ring derivatives. Remarkably, structural effects on quinolone lethality were not explained by the recently described X-ray crystal structures of fluoroquinolone-topoisomerase IV-DNA complexes, suggesting the existence of an additional drug-binding state.
喹诺酮类药物通过两种机制迅速杀死细菌,一种需要蛋白质合成,另一种不需要。后者在蛋白质合成抑制剂氯霉素存在下被测量为致死作用,被 N-1 环丙基和 C-8 甲氧基取代基增强,如高度致死化合物 PD161144 所见。在一些化合物中,如左氧氟沙星,N-1 和 C-8 取代基融合。为了评估环融合对杀伤的影响,合成了左氧氟沙星和 PD161144 的结构衍生物,并在大肠杆菌中进行了检查。PD161144 的融合环衍生物在氯霉素存在下表现出明显缺乏致死活性。一般来说,当允许蛋白质合成时,环融合对致死活性的影响很小,但融合会降低在没有蛋白质合成的情况下的致死活性,程度取决于 C-7 环结构。其他融合环氟喹诺酮类药物,帕珠沙星、马波沙星和鲁氟沙星,在氯霉素存在下也表现出降低的活性。能量最小化建模揭示了反式定向 N-1 环丙基和 C-8 甲氧基部分的空间相互作用使喹诺酮核心扭曲,使这些基团刚性地垂直于核心环定向,并限制 C-7 环的旋转自由度。这些特征在融合环衍生物中没有观察到。值得注意的是,最近描述的氟喹诺酮-拓扑异构酶 IV-DNA 复合物的 X 射线晶体结构不能解释结构对喹诺酮类药物致死性的影响,这表明存在另一种药物结合状态。